vs
Side-by-side financial comparison of F5, Inc. (FFIV) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
F5, Inc. is the larger business by last-quarter revenue ($822.5M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). F5, Inc. runs the higher net margin — 21.9% vs 6.8%, a 15.1% gap on every dollar of revenue. On growth, F5, Inc. posted the faster year-over-year revenue change (7.3% vs -1.7%). Over the past eight quarters, F5, Inc.'s revenue compounded faster (9.9% CAGR vs -0.1%).
F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FFIV vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $822.5M | $493.8M |
| Net Profit | $180.1M | $33.7M |
| Gross Margin | 81.5% | — |
| Operating Margin | 26.0% | 9.9% |
| Net Margin | 21.9% | 6.8% |
| Revenue YoY | 7.3% | -1.7% |
| Net Profit YoY | 8.2% | 10.5% |
| EPS (diluted) | $3.10 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $822.5M | $493.8M | ||
| Q3 25 | $810.1M | $492.9M | ||
| Q2 25 | $780.4M | $468.8M | ||
| Q1 25 | $731.1M | $458.4M | ||
| Q4 24 | $766.5M | $502.4M | ||
| Q3 24 | $746.7M | $511.2M | ||
| Q2 24 | $695.5M | $504.3M | ||
| Q1 24 | $681.4M | $495.1M |
| Q4 25 | $180.1M | $33.7M | ||
| Q3 25 | $190.5M | $71.7M | ||
| Q2 25 | $189.9M | $39.3M | ||
| Q1 25 | $145.5M | $20.7M | ||
| Q4 24 | $166.4M | $30.5M | ||
| Q3 24 | $165.3M | $19.4M | ||
| Q2 24 | $144.1M | $-153.0M | ||
| Q1 24 | $119.0M | $4.0M |
| Q4 25 | 81.5% | — | ||
| Q3 25 | 82.2% | — | ||
| Q2 25 | 81.0% | — | ||
| Q1 25 | 80.7% | — | ||
| Q4 24 | 81.7% | — | ||
| Q3 24 | 80.8% | — | ||
| Q2 24 | 80.4% | — | ||
| Q1 24 | 79.3% | — |
| Q4 25 | 26.0% | 9.9% | ||
| Q3 25 | 25.4% | 13.8% | ||
| Q2 25 | 25.2% | 12.8% | ||
| Q1 25 | 21.7% | 7.0% | ||
| Q4 24 | 26.8% | 7.8% | ||
| Q3 24 | 25.6% | 6.6% | ||
| Q2 24 | 23.4% | -31.3% | ||
| Q1 24 | 20.5% | 3.2% |
| Q4 25 | 21.9% | 6.8% | ||
| Q3 25 | 23.5% | 14.5% | ||
| Q2 25 | 24.3% | 8.4% | ||
| Q1 25 | 19.9% | 4.5% | ||
| Q4 24 | 21.7% | 6.1% | ||
| Q3 24 | 22.1% | 3.8% | ||
| Q2 24 | 20.7% | -30.3% | ||
| Q1 24 | 17.5% | 0.8% |
| Q4 25 | $3.10 | $0.40 | ||
| Q3 25 | $3.25 | $0.84 | ||
| Q2 25 | $3.25 | $0.46 | ||
| Q1 25 | $2.48 | $0.24 | ||
| Q4 24 | $2.82 | $0.37 | ||
| Q3 24 | $2.79 | $0.23 | ||
| Q2 24 | $2.44 | $-1.84 | ||
| Q1 24 | $2.00 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $3.5B | $865.9M |
| Total Assets | $6.3B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.2B | $375.2M | ||
| Q3 25 | $1.3B | $340.1M | ||
| Q2 25 | $1.4B | $224.7M | ||
| Q1 25 | $1.3B | $99.0M | ||
| Q4 24 | $1.2B | $229.9M | ||
| Q3 24 | $1.1B | $103.8M | ||
| Q2 24 | $935.6M | $19.4M | ||
| Q1 24 | $903.5M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.5B | $865.9M | ||
| Q3 25 | $3.6B | $890.7M | ||
| Q2 25 | $3.5B | $833.8M | ||
| Q1 25 | $3.3B | $789.2M | ||
| Q4 24 | $3.2B | $764.9M | ||
| Q3 24 | $3.1B | $732.5M | ||
| Q2 24 | $3.0B | $706.5M | ||
| Q1 24 | $2.9B | $856.2M |
| Q4 25 | $6.3B | $2.2B | ||
| Q3 25 | $6.3B | $2.2B | ||
| Q2 25 | $6.1B | $2.1B | ||
| Q1 25 | $5.9B | $2.0B | ||
| Q4 24 | $5.9B | $2.2B | ||
| Q3 24 | $5.6B | $2.1B | ||
| Q2 24 | $5.4B | $2.0B | ||
| Q1 24 | $5.4B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $159.2M | $114.1M |
| Free Cash FlowOCF − Capex | $149.5M | — |
| FCF MarginFCF / Revenue | 18.2% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $861.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.2M | $114.1M | ||
| Q3 25 | $208.1M | $137.3M | ||
| Q2 25 | $282.2M | $137.2M | ||
| Q1 25 | $256.6M | $-117.5M | ||
| Q4 24 | $202.8M | $133.0M | ||
| Q3 24 | $246.5M | $91.8M | ||
| Q2 24 | $159.0M | $107.0M | ||
| Q1 24 | $221.6M | $-125.2M |
| Q4 25 | $149.5M | — | ||
| Q3 25 | $191.9M | — | ||
| Q2 25 | $273.7M | — | ||
| Q1 25 | $246.1M | — | ||
| Q4 24 | $194.7M | — | ||
| Q3 24 | $240.4M | — | ||
| Q2 24 | $153.1M | — | ||
| Q1 24 | $212.2M | — |
| Q4 25 | 18.2% | — | ||
| Q3 25 | 23.7% | — | ||
| Q2 25 | 35.1% | — | ||
| Q1 25 | 33.7% | — | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 32.2% | — | ||
| Q2 24 | 22.0% | — | ||
| Q1 24 | 31.1% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.88× | 3.39× | ||
| Q3 25 | 1.09× | 1.91× | ||
| Q2 25 | 1.49× | 3.49× | ||
| Q1 25 | 1.76× | -5.66× | ||
| Q4 24 | 1.22× | 4.36× | ||
| Q3 24 | 1.49× | 4.72× | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 1.86× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FFIV
| Services | $412.2M | 50% |
| Products | $410.3M | 50% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
